Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TMS in Preclinical and Prodromal AD: Modulation of Brain Networks and Memory

NCT04294888 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04294888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04294888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TMS in Preclinical and Prodromal AD: Modulation of Brain Networks and Memory
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Terminated
Start date
March 2, 2020
Completion date
June 23, 2021
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging, alzheimer disease, mild cognitive impairment